A combination of two drugs that treats COVID-19, influenza and proteinuria, a condition where urine contains high levels of protein caused by CKD.

A broad-spectrum antiviral to be administered via nasal spray with potent activity against SARS-COV-2, Influenza A, and B viruses.

A vaccine developed to prevent the Spike protein from the coronavirus binding to the ACE2 receptor on human cells, thus protecting against the disease

A two gene test for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

A specifically designed hood to contain droplets and aerosols expired by an infectious or potentially infectious patient

Uses InSignia™ technology that enhances gene expression measurement to support classification of respiratory viral illness, including COVID-19.